NORTHWEST BIOTHERAPEUTICS INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate of 83.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2026-03-31 was 83.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2024-03-31 was 73.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-06-30 was 99.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for the quarter ending 2022-03-31 was 95.00%.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2024 was 73.00%, a 15.12% decline from fiscal 2023.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2023 was 86.00%, a 13.13% decline from fiscal 2022.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2022 was 99.00%, a 2.06% increase from fiscal 2021.
- NORTHWEST BIOTHERAPEUTICS INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected volatility rate for fiscal 2021 was 97.00%, a 1.02% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 83.00% 10-Q · filed 2026-08-14 | ||||
| 2026-03-31 | 83.00% 10-Q · filed 2026-05-15 | ||||
| 2025-12-31 | 66.00% 10-Q · filed 2026-05-15 | 77.00% 10-K · filed 2026-04-15 | |||
| 2025-09-30 | 77.00% 10-Q · filed 2025-11-14 | ||||
| 2025-06-30 | 77.00% 10-Q · filed 2026-08-14 | ||||
| 2024-12-31 | 73.00% 10-K · filed 2026-04-15 | ||||
| 2024-09-30 | 73.00% 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | 73.00% 10-Q · filed 2024-08-09 | ||||
| 2024-03-31 | 73.00% 10-Q · filed 2024-05-10 | ||||
| 2023-12-31 | 86.00% 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | 84.00% 10-Q · filed 2023-11-09 | ||||
| 2022-12-31 | 99.00% 10-K · filed 2024-03-05 | ||||
| 2022-09-30 | 99.00% 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | 99.00% 10-Q · filed 2022-08-09 | ||||
| 2022-03-31 | 95.00% 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | 97.00% 10-K · filed 2024-03-05 | ||||
| 2020-12-31 | 98.00% 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | 98.00% 10-Q · filed 2021-01-15 | ||||
| 2019-12-31 | 86.00% 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | 93.00% 10-Q · filed 2019-11-12 | ||||
| 2018-12-31 | 96.00% 10-K · filed 2020-03-16 | ||||
| 2018-09-30 | 96.00% 10-Q · filed 2018-11-16 | ||||
| 2018-06-30 | 95.00% 10-Q · filed 2018-08-14 | ||||
| 2018-03-31 | 93.00% 10-Q · filed 2018-05-16 | ||||
| 2017-12-31 | 96.00% 10-K · filed 2019-04-02 | ||||
| 2017-09-30 | 96.00% 10-Q · filed 2017-11-20 | ||||
| 2017-06-30 | 96.00% 10-Q · filed 2017-08-21 | ||||
| 2012-12-31 | 193.50% 10-K · filed 2014-04-01 | ||||
| 2011-12-31 | 193.50% 10-K · filed 2013-04-08 |